The overexpression of EFEMP1, HtrA1, PAM, and SDF4 in enhanced exosomes compared to naïve exosomes underscores their potential therapeutic relevance in treating ovarian dysfunction. This evidence concerns the gene EFEMP1 and ovarian dysfunction.